Candel Therapeutics Inc. (CADL)
NASDAQ · Healthcare
Candel Therapeutics Inc. annual/quarterly total liabilities history from 2020 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Candel Therapeutics Inc. total liabilities for the quarter ending December 31, 2022 were 30.0M, a 19.58% increase year-over-year.
- Candel Therapeutics Inc. total liabilities for 2022 were 30.0M, a 19.58% increase from 2021.
- Candel Therapeutics Inc. total liabilities for 2021 were 25.1M, a 96.09% increase from 2020.
- Candel Therapeutics Inc. total liabilities for 2020 were 12.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Candel Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2022 | $30 |
| 2021 | $25 |
| 2020 | $13 |
| Candel Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2022-12-31 | $30 |
| 2021-12-31 | $25 |
| 2020-12-31 | $13 |
Candel Therapeutics Inc. Total Liabilities — FAQ
Candel Therapeutics Inc. (CADL) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CADL's total liabilities history?
The chart and table above show Candel Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.